Re-challenge of Anti-EGFR for Patients With RAS/BRAF Wild-type Metastatic CRC
收藏NIAID Data Ecosystem2026-03-11 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2326638
下载链接
链接失效反馈官方服务：
资源简介：
The aim of the trial is to study the efficacy and safety of Cetuximab re-challenge for Chinese Patients with RAS/BRAF wild-type Metastatic Colorectal Cancer.
创建时间：
2020-01-15
